CXCL12 and neoplasm: In a conditional prostate-specific Pten/Tp53 knockout mouse model, Cabozantinib treatment induced tumor clearance by massive infiltration of neutrophils, and this was dependent to CXCL12 and HMGB1 molecules that acted as chemoattractants (25).